Aquestive Therapeutics (AQST) Free Cash Flow (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Free Cash Flow of -$14.9 million for Q1 2026, up 36.87% year-over-year from -$10.9 million in Q1 2025, and down 84.71% quarter-over-quarter from -$8.0 million in Q4 2025.
Aquestive Therapeutics (AQST) Free Cash Flow (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Free Cash Flow history runs 10 years deep, the most recent figure standing at -$14.9 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 36.87% year-over-year to -$14.9 million; the TTM figure through Mar 2026 stood at -$43.8 million (up 10.67% YoY), while the FY2025 annual figure was -$52.5 million, down 46.12% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$14.9 million, down from -$8.0 million in the prior quarter.
- The five-year high for Free Cash Flow was $8.8 million in Q1 2023, with the low at -$23.5 million in Q1 2025.
- The 5-year median for Free Cash Flow is -$7.9 million (2025), against an average of -$7.1 million.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow surged 197.63% in 2022, then tumbled 375.58% in 2024.
- Aquestive Therapeutics' Free Cash Flow stood at $8.4 million in 2022, then tumbled by 147.23% to -$4.0 million in 2023, then sank by 67.75% to -$6.6 million in 2024, then decreased by 21.0% to -$8.0 million in 2025, then slumped by 84.71% to -$14.9 million in 2026.
- Business Quant data shows AQST's Free Cash Flow at -$14.9 million in Q1 2026, -$8.0 million in Q4 2025, and -$13.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Aquestive Therapeutics | 560.60 Mn | 560.60 Mn | 9.80 Mn | -9.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.65 Mn |
| Jun 30, 2026 | -9.65 Mn |
| Mar 31, 2026 | -14.86 Mn |
| Mar 31, 2026 | -14.86 Mn |
| Dec 31, 2025 | -8.04 Mn |
| Dec 31, 2025 | -8.04 Mn |
| Sep 30, 2025 | -13.04 Mn |
| Sep 30, 2025 | -13.04 Mn |
| Jun 30, 2025 | -7.86 Mn |
| Jun 30, 2025 | -7.86 Mn |
| Mar 31, 2025 | -23.54 Mn |
| Mar 31, 2025 | -23.54 Mn |
| Dec 31, 2024 | -6.65 Mn |
| Dec 31, 2024 | -6.65 Mn |
| Sep 30, 2024 | -11.88 Mn |
| Sep 30, 2024 | -11.88 Mn |
| Jun 30, 2024 | -6.98 Mn |
| Jun 30, 2024 | -6.98 Mn |
| Mar 31, 2024 | -10.41 Mn |
| Mar 31, 2024 | -10.41 Mn |